Biorchestra
Pre-clinicalDevelops RNA-based therapeutics targeting neurological and inflammatory diseases using proprietary delivery technology.
Founded
2013
Focus
RNA & Gene Therapy
About
Develops RNA-based therapeutics targeting neurological and inflammatory diseases using proprietary delivery technology.
Funding History
2Total raised: $80M
Series B$50MUndisclosedAug 15, 2023
Series A$30MUndisclosedNov 15, 2021
Company Info
TypePrivate
Founded2013
LocationDaejeon, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile